侵袭性曲霉病合并感染的相关因素:回顾性队列研究
该单中心回顾性队列纳入1997至2017年690例侵袭性曲霉病患者,39.4%诊断合并感染,异基因造血干细胞移植、发热、气管插管等因素与合并感染独立相关,合并感染与12周死亡率升高独立相关(调整HR 1.5,95%CI 1.1-1.9,p<0.01)。
要点
- 侵袭性曲霉病患者中合并感染常见,占39.4%。
- 发热、气管插管、淋巴细胞减少等是合并感染的独立相关因素。
- 合并感染独立增加12周死亡率(调整HR 1.5)。
核心结论
- 侵袭性曲霉病患者合并感染频繁,且与12周死亡率升高独立相关。
研究设计与样本
- 单中心回顾性队列研究,纳入1997至2017年连续690例疑似、可能或确诊侵袭性曲霉病患者。
- 合并感染定义为在曲霉病首个征象前后7天内出现的所有合并感染。
- 采用多变量分析识别与合并感染和死亡率相关的因素。
主要发现
- 690例患者中位年龄57岁(范围7天至90岁),272/690例(39.4%,95%CI 35.8-43.2)诊断合并感染。
- 合并感染部位:仅肺部131/272例(48%),仅血流66/272例(24%),其他/多部位75/272例(28%)。
- 合并感染病原体:细菌110/272例(40%),病毒58/272例(21%),真菌57/272例(21%),寄生虫5/272例(2%),多种病原体42/272例(15%)。
- 调整分析中与合并感染相关的因素包括:异基因造血干细胞移植(OR 2.3,95%CI 1.2-4.4)、其他血液恶性肿瘤(OR 2.1,95%CI 1.2-3.8)、其他基础疾病(OR 4.3,95%CI 1.4-13.6)、淋巴细胞减少(OR 1.7,95%CI 1.1-2.5)、C反应蛋白>180 mg/L(OR 1.9,95%CI 1.2-3.0)、发热(OR 2.4,95%CI 1.5-4.1)、气管插管(OR 2.6,95%CI 1.5-4.7)、分离出两种或以上不同曲霉物种(OR 2.7,95%CI 1.1-6.3)、胸部CT非结节性病变(OR 2.2,95%CI 1.3-3.7和OR 2.2,95%CI 1.2-4.0)。
- 合并感染独立与更高的12周死亡率相关(调整HR 1.5,95%CI 1.1-1.9,p<0.01)。
临床怎么用
- 对侵袭性曲霉病患者应警惕合并感染,尤其存在发热、气管插管、淋巴细胞减少等高危因素时。
- 合并感染与死亡率升高相关,需积极评估和干预。
局限性
- 单中心回顾性研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the coinfections in invasive aspergillosis (IA), to identify factors associated with coinfections, and to evaluate the impact of coinfection on mortality. PATIENTS AND METHODS: We conducted a monocentric retrospective study of consecutive putative, probable, or proven IA that occurred between 1997 and 2017. All coinfections, with an onset within 7 days before or after the first sign of aspergillosis, were identified. Factors associated with coinfections and mortality were analysed by multivariable analysis. RESULTS: Among the 690 patients with IA included in the study, the median age was 57 years (range 7 days to 90 years). A coinfection was diagnosed in 272/690 patients (39.4%, 95%CI 35.8-43.2). The location of this coinfection was pulmonary only in 131/272 patients (48%), bloodstream only in 66/272 patients (24%) and other/multiple sites in 75/272 patients (28%). Coinfections were bacterial (110/272 patients, 40%), viral (58/272, 21%), fungal (57/272, 21%), parasitic (5/272, 2%) or due to multiple types of pathogens (42/272, 15%). Factors associated with a coinfection in adjusted analysis were: allogeneic haematopoietic stem-cell transplantation (OR 2.3 (1.2-4.4)), other haematological malignancies (OR 2.1 (1.2-3.8)), other underlying diseases (OR 4.3 (1.4-13.6)), lymphopenia (OR 1.7 (1.1-2.5)), C-reactive protein >180 mg/L (OR 1.9 (1.2-3.0)), fever (OR 2.4 (1.5-4.1)), tracheal intubation (OR 2.6 (1.5-4.7)), isolation of two or more different Aspergillus species (OR 2.7 (1.1-6.3)), and the presence of non-nodular lesions on chest computed tomography (OR 2.2 (1.3-3.7) and OR 2.2 (1.2-4.0)). Coinfections were independently associated with a higher mortality at week 12 (adjusted HR 1.5 (1.1-1.9), p < 0.01). CONCLUSIONS: Coinfections are frequent in IA patients and are associated with higher mortality.
引用
- Danion F, Duval C, Séverac F, et al. Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study. Clin Microbiol Infect. 2021. PMID: 33662543. doi:10.1016/j.cmi.2021.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。